Dr. Vijay Kudithipudi, MD

Dr. Kudithipudi practices at OhioHealth Grant Medical Center in Columbus, Ohio, part of OhioHealth.

Dr. Kudithipudi's NPI, 1457618548, was assigned on April 13, 2012. Dr. Kudithipudi graduated from Northeastern Ohio University College of Medicine in 2012. Dr. Kudithipudi holds Ohio license 35.131074.

Dr. Kudithipudi's primary practice is OhioHealth Grant Medical Center, at 111 South Grant Avenue, Columbus, OH 43215 in Franklin County. The practice phone is (614) 566-9164.

Dr. Kudithipudi's primary practice is OhioHealth Grant Medical Center in Columbus, Ohio, part of OhioHealth. Dr. Kudithipudi is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Kudithipudi to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kudithipudi practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kudithipudi's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kudithipudi is licensed in Ohio.

CMS data shows 1,568 Medicare services from Dr. Kudithipudi across 17 procedure codes in 2024, for 205 Medicare patients. Medicare paid $121,830 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 205 Medicare patients who saw Dr. Kudithipudi in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have cancer, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kudithipudi's median patient age at 71, with 51% women.

In 2024, Dr. Kudithipudi wrote 404 Medicare Part D claims for 130 patients. 90% of them were for generic drugs. CMS names the drug for 248 of them, across 13 drugs with 11 or more claims each, at $34,902 in total drug cost. In 2023, CMS named 187 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Kudithipudi for performance year 2024, reported as part of a group. Dr. Kudithipudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Kudithipudi, published from 2015 to 2025. The most frequent topics are Radiotherapy Planning, Computer-Assisted and Tomography, X-Ray Computed. Dr. Kudithipudi's most frequent co-authors are Ngoc L. Thai, MD, Peter Lawrence Abrams, MD and Victor Mordecai Awuor, DO.

Dmand AI links Dr. Kudithipudi to 1 clinical trial. Conditions studied include Brain Neoplasms and Central Nervous System Neoplasms.

CMS Open Payments shows 19 general payments to Dr. Kudithipudi from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $230.

Dr. Kudithipudi graduated from Northeastern Ohio University College of Medicine in 2012.